Debt
Latest Debt News
Did Medicare Pay for a Test You Never Received? A New Fraud Crackdown Gives Seniors a Reason to Look
CMS says its latest enforcement actions have stopped more than $1.6 billion in potentially improper Medicare laboratory payments. Check your…
CMS Is Targeting Unauthorized Health Insurance Enrollments—Here’s What Consumers Should Check
CMS received thousands of complaints about Marketplace plans being changed or created without consumers’ consent. Check your plan, premium, application…
157 Lab Providers Lost Medicare Billing Privileges—Here’s Why Checking Your Medicare Statement Matters
CMS says 157 fraudulent lab providers were revoked from Medicare, contributing $732 million in savings. Beneficiaries should review statements for…
One Lucky Break Is All It Takes
If you find value in these articles, please share them with your inner circle and encourage them to Sign Up for…
The FDIC Says the Average Savings Account Pays Just 0.38%—How Does Yours Compare?
The FDIC’s latest national savings rate is just 0.38%. On larger cash balances, moving to a competitive high-yield account could…
This Tiny Crease Has Been Linked to Heart Disease
A diagonal earlobe crease known as Frank’s sign has been associated with coronary artery disease in multiple studies. Researchers caution…
6 Charges on Your Medicare Statement You Should Never Ignore
Medicare recommends comparing your claims with your own records to make sure you received every service and supply listed. Equipment…
FTC Says Payment Processor Helped 1,000+ Sham Merchants Charge Consumers — $12 Million Settlement Proposed
The FTC alleges Humboldt Merchant Services processed payments for more than 1,000 sham merchants, highlighting why consumers should investigate unfamiliar…
IRS Urges Taxpayers to Get an IP PIN to Help Stop Tax Identity Theft
The IRS is encouraging taxpayers to use Identity Protection PINs, secure IRS Online Accounts and multifactor authentication to make it…
FDA Approves Etcamah for Advanced Breast Cancer Before Imaging Shows Disease Progression
FDA has granted accelerated approval to Etcamah for certain patients with advanced breast cancer after an ESR1 resistance mutation is…
